Lactoferrin increases both resistance to Salmonella typhimurium infection and the production of antibodies in mice

Immunology Letters

Volumn 134, Issue 1, 2010, Pages 35-46

  Drago Serrano, Maria Elisa ^a,b   Rivera Aguilar, Victor ^c   Reséndiz Albor, Aldo A ^d   Campos Rodríguez, Rafael ^d  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Bacterial translocation; Intestinal IgA; Lactoferrin; Murine typhoid fever

Indexed keywords

BACTERIAL PROTEIN; BOVINE LACTOFERRIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LACTOFERRIN; UNCLASSIFIED DRUG;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; COLONY FORMING UNIT; DILUTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FECES ANALYSIS; INFECTION RESISTANCE; INTESTINE FLUID; LIVER; LOW DRUG DOSE; MALE; MORTALITY; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN; SURVIVAL RATE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL TRANSLOCATION; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTESTINES; LACTOFERRIN; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SURVIVAL RATE; TIME FACTORS;

EID: 78049271746     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.08.007     Document Type: Article

References (44)

1. Baker E.N., Baker H.M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 2009, 91:3-10.
2. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica 1995, 80:252-267.
3. Russell M.W., Bobek L.A., Brock J.H., Hajishengallis G., Tenovuo J. Innate humoral defense factors. Mucosal immunology 2005, 73-93. Elsevier, Amsterdam. J. Mestecky, J. Bienenstock, M.E. Lamm, L. Mayer, J.R. McGhee, W. Strober (Eds.).
4. Goldoni P., Sinibaldi L., Valenti P., Orsi N. Metal complexes of lactoferrin and their effect on the intracellular multiplication of Legionella pneumophila. Biometals 2000, 13:15-22.
5. Naidu S.S., Svensson U., Kishore A.R., Naidu A.S. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 1993, 37:240-245.
6. Appelmelk B.J., An Y.Q., Geerts M., Thijs B.H., de Boer H.A., MacLaren D.M., et al. Lactoferrin is a lipid A binding protein. Infect Immun 1994, 62:2628-2632.
7. Puddu P., Valenti P., Gessani S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 2009, 911:11-18.
8. Miyauchi H., Hashimoto S., Nakajima M., Shinoda I., Fukuwatari Y., Hayasawa H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell Immunol 1998, 187:34-37.
9. Zagulski T., Lipiński P., Zagulska A., Jarza{ogonek};bek Z. Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system. Int J Exp Pathol 1998, 79:117-123.
10. Edde L., Hipolito R.B., Hwang F.F., Headon D.R., Shalwitz R.A., Sherman M.P. Lactoferrin protects neonatal rats from gut related systemic infection. Am J Physiol Gastrointest Liver Physiol 2001, 281:G1140-G1150.
11. Fisher R., Debbabi H., Dubarry M., Boyaka P., Tomé D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem Cell Biol 2006, 84:303-311.
12. Debbabi H., Dubarry M., Rautureau M., Tome D. Bovine lactoferrin induces both mucosal and systemic responses in mice. J Dairy Res 1998, 65:283-293.
13. Sfeir R.M., Dubarry M., Boyaka P.N., Rautureau M., Tomé D. The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. J Nutr 2004, 134:403-409.
14. Fisher R., Debbabi H., Blais A., Dubarry M., Rautureau M., Boyaka P., Tome D. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues. Int Immunopharmacol 2007, 7:1387-1393.
15. Kawasaki Y., Tazume S., Shimizu K., Matsuzawa H., Dosako S., Isoda H., et al. Inhibitory effects of bovine lactoferrin on the adherence of Escherichia coli to host cells. Biosci Biotechnol Biochem 2000, 64:348-354.
16. Wang X., Hirmo S., Willén R., Wadström T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BALB/cA mouse model. J Med Microbiol 2001, 50:430-435.
17. Lee H.Y., Park J.H., Seok S.H., Baek M.W., Kim D.J., Lee B.H., et al. Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes. J Med Microbiol 2005, 54:1049-1054.
18. Gomez H.F., Ochoa T.J., Herrera-Insua I., Carlin L.G., Cleary T.G. Lactoferrin protects rabbits from Shigella flexneri induced inflammatory enteritis. Infect Immun 2002, 70:7050-7053.
19. Santos R.L., Zhang S., Tsolis R.M., Kingsley R.A., Adams L.G., Bäumler A.J. Animal models of Salmonella infections: enteritis versus typhoid fever. Microb Infect 2001, 3:1335-1344.
20. Worley M.J., Nieman G.S., Geddes K., Heffron F. Salmonella typhimurium disseminates within its host by manipulating the motility of infected cells. Proc Natl Acad Sci 2006, 103:17915-17920.
21. Hashizume T., Togawa A., Nochi T., Igarashi O., Kweon M., Kiyono H., et al. Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp. Infect Immun 2008, 76:927-934.
22. Martinoli C., Chiavelli A., Rescigno M. Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 2007, 27:975-984.
23. McSorley S.J., Jenkins M.K. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar Typhimurium. Infect Immun 2000, 68:3344-3348.
24. Cunningham A.F., Gaspal F., Serre K., Mohr E., Henderson I.R., Scott-Tucker A., et al. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol 2007, 178:6200-6207.
25. Bessler H.C., De Oliveira I.R., Giugliano L.G. Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells. Microbiol Immunol 2006, 50:877-882.
26. Ellison R.T., Giehl T.J. Killing of Gram negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991, 88:1080-1091.
27. Czirok E., Milch H., Nemeth K., Gado I. In vitro and in vivo (LD50) effects of human lactoferrin on bacteria. Acta Microbiol Hung 1990, 37:55-71.
28. Paik G., Suggs M.T. Reagents, stains, and miscellaneous test procedures. Manual of clinical microbiology 1974, 930-950. American Society for Microbiology, Washington. E.H. Lennette, E.H. Spaulding, J.P. Truant (Eds.).
29. Campos Rodriguez R., Quintanar Stephano R., Jarillo Luna R.A., Oliver Aguillon G., Ventura Juarez J., Rivera Aguilar V., et al. Hypophysectomy and neurointermediate pituitary lobectomy reduce serum immunoglobulin M (IgM) and IgG and intestinal IgA responses to Salmonella enterica serovar Typhimurium in rats. Infect Immun 2006, 74:1883-1889.
30. Towbin H., Satquet T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354.
31. Heithoff D.M., Sinsheimer R.L., Low D.A., Mahan M.J. An essential role for DNA adenine methylation in bacterial virulence. Science 1999, 284:967-970.
32. Håversen L.A., Engberg I., Baltzer L., Dolphin G., Hanson LÅ, Mattsby-Baltzer I. Human lactoferrin and peptides derived from a surface exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 2000, 68:5816-5823.
33. Yamauchi K., Tomita M., Giehl T.J., Ellison R.T. Antibacterial activity of lactoferrin and a pepsin derived lactoferrin peptide fragment. Infect Immun 1993, 61:719-728.
34. Collins H.L., Kaufmann S.H., Schiable U.E. Iron chelation via deferoxmine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase dependent respiratory burst. J Immunol 2002, 168:3458-3463.
35. Wijburg O., Uren T.K., Simpfendorfer K., Johansen F.E., Brandtzaeg P., Strugnell R.A. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med 2006, 203:21-26.
36. Matsiota-Bernard P., Mahana W., Avrameas S., Nauciel C. Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice. Immunology 1993, 79:375-380.
37. Mittrücker H.W., Raupach B., Köhler A., Kaufmann S.H.E. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 2000, 164:1648-1652.
38. Mosquito S., Ochoa T.J., Cok J., Cleary T.G. Effect of bovine lactoferrin Salmonella ser. Typhimurium infection in mice. Biometals 2010, 23:515-521.
39. Teraguchi S., Shin K., Ogata T., Kingaku M., Kaino A., Miyauchi H., Fukuwatari Y., Shimamura S. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk. Appl Environ Microbiol 1995, 61:4131-4134.
40. Mastroeni P. Immunity to systemic Salmonella infections. Curr Mol Med 2002, 2:393-406.
41. Michetti P., Mahan M.J., Slauch J.M., Mekalanos J.J., Neutra M.R. Monoclonal secretory immunoglobulin IgA protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992, 60:1786-1792.
42. Uppington H., Menager N., Boross P., Wood J., Sheppard M., Verbeek S., et al. Effect of immune serum and role of individual Fcγ receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology 2006, 119:147-158.
43. Mestecky J., Russel M.W. Specific antibody reactivity, glycan heterogeneity and polyreactivity contribute to protective activity of S-IgA at mucosal surfaces. Immunol Lett 2009, 124:57-62.
44. Mastroeni P., Villarreal-Ramos B., Hormaeche C.E. Adoptive transfer of immunity to oral challenge with virulent Salmonella in innately susceptible BALB/c mice requires both immune serum and T cells. Infect Immun 1993, 61:3981-3984.